Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Bowden

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|June 1, 2010
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markersAlexander J V Thompson, Tin Nguyen, David Iser, et al.
Journal of Viral Hepatitis|May 9, 2020
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis BLilly Yuen, Peter A Revill, Gillian Rosenberg, et al.
Antiviral Therapy|April 28, 2006
A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BSeng Gee Lim, Chun-too Wai, Yin Mei Lee, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-αJacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009Ellen J Donnan, James E Fielding, Joy E Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
Journal of Virology|November 11, 2011
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative diseaseChristopher P Desmond, Silvana Gaudieri, Ian R James, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|June 1, 2010
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markersAlexander J V Thompson, Tin Nguyen, David Iser, et al.
Journal of Viral Hepatitis|May 9, 2020
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis BLilly Yuen, Peter A Revill, Gillian Rosenberg, et al.
Antiviral Therapy|April 28, 2006
A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BSeng Gee Lim, Chun-too Wai, Yin Mei Lee, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-αJacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009Ellen J Donnan, James E Fielding, Joy E Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
Journal of Virology|November 11, 2011
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative diseaseChristopher P Desmond, Silvana Gaudieri, Ian R James, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
Pageof 10